KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Eli Lilly (LLY) Other Operating Expenses (2016 - 2019)

Historic Other Operating Expenses for Eli Lilly (LLY) over the last 8 years, with Q4 2019 value amounting to -$151.7 million.

  • Eli Lilly's Other Operating Expenses rose 2123.57% to -$151.7 million in Q4 2019 from the same period last year, while for Sep 2020 it was -$151.7 million, marking a year-over-year increase of 7539.33%. This contributed to the annual value of -$9.1 billion for FY2019, which is 1093.12% down from last year.
  • Per Eli Lilly's latest filing, its Other Operating Expenses stood at -$151.7 million for Q4 2019, which was up 2123.57% from -$423.9 million recorded in Q1 2019.
  • Eli Lilly's Other Operating Expenses' 5-year high stood at $25.5 million during Q2 2018, with a 5-year trough of -$423.9 million in Q1 2019.
  • Moreover, its 5-year median value for Other Operating Expenses was -$90.2 million (2015), whereas its average is -$136.1 million.
  • In the last 5 years, Eli Lilly's Other Operating Expenses plummeted by 79340.66% in 2017 and then soared by 15100.0% in 2018.
  • Quarter analysis of 5 years shows Eli Lilly's Other Operating Expenses stood at -$144.9 million in 2015, then plummeted by 100.14% to -$290.0 million in 2016, then skyrocketed by 84.69% to -$44.4 million in 2017, then crashed by 333.78% to -$192.6 million in 2018, then rose by 21.24% to -$151.7 million in 2019.
  • Its Other Operating Expenses was -$151.7 million in Q4 2019, compared to -$423.9 million in Q1 2019 and -$192.6 million in Q4 2018.